Spearheading a Novel Compound Targeting the IL-4Ra Cytokine Receptor in Atopic Dermatitis
Time: 12:00 pm
day: Day 1 AM - Track A
Details:
- Describing the target binding and Th2 cell modulation
- Clinical responses from a phase 2b clinical trial in atopic dermatitis
- Future clinical development
